Forward-looking Statements
The following discussion of the Company's financial condition and results of
operations should be read together with TD Group's consolidated financial
statements and the related notes included elsewhere in this Quarterly Report on
Form 10-Q. References in this section to "TransDigm," "the Company," "we," "us,"
"our," and similar references refer to TD Group, TransDigm Inc. and TransDigm
Inc.'s subsidiaries, unless the context otherwise indicates.
This Quarterly Report on Form 10-Q contains both historical and "forward-looking
statements" within the meaning of Section 21E of the Exchange Act, and 27A of
the Securities Act. All statements other than statements of historical fact
included that address activities, events or developments that we expect, believe
or anticipate will or may occur in the future are forward-looking statements,
including, in particular, the statements about our plans, objectives, strategies
and prospects regarding, among other things, our financial condition, results of
operations and business. We have identified some of these forward-looking
statements with words like "believe," "may," "will," "should," "expect,"
"intend," "plan," "predict," "anticipate," "estimate" or "continue" and other
words and terms of similar meaning. These forward-looking statements may be
contained throughout this Quarterly Report on Form 10-Q. These forward-looking
statements are based on current expectations about future events affecting us
and are subject to uncertainties and factors relating to, among other things,
our operations and business environment, all of which are difficult to predict
and many of which are beyond our control. Many factors mentioned in our
discussion in this Quarterly Report on Form 10-Q, including the risks outlined
under "Risk Factors," will be important in determining future results. Although
we believe that the expectations reflected in these forward-looking statements
are reasonable, we do not know whether our expectations will prove correct. They
can be affected by inaccurate assumptions we might make or by known or unknown
risks and uncertainties, including those described under "Risk Factors" in the
Quarterly Report on Form 10-Q. Since our actual results, performance or
achievements could differ materially from those expressed in, or implied by,
these forward-looking statements, we cannot give any assurance that any of the
events anticipated by these forward-looking statements will occur or, if any of
them does occur, what impact they will have on our business, results of
operations and financial condition. You are cautioned not to place undue
reliance on these forward-looking statements, which speak only as of the date
they are made. We do not undertake any obligation to update these
forward-looking statements or the risk factors contained in this Quarterly
Report on Form 10-Q to reflect new information, future events or otherwise,
except as may be required under federal securities laws.
Important factors that could cause actual results to differ materially from the
forward-looking statements made in this Quarterly Report on Form 10-Q include
but are not limited to: the impact that the COVID-19 pandemic has on our
business, results of operations, financial condition and liquidity; the
sensitivity of our business to the number of flight hours that our customers'
planes spend aloft and our customers' profitability, both of which are affected
by general economic conditions; future geopolitical or other worldwide events;
cyber-security threats and natural disasters; our reliance on certain customers;
the U.S. defense budget and risks associated with being a government supplier
including government audits and investigations; failure to maintain government
or industry approvals; failure to complete or successfully integrate
acquisitions, including our acquisition of Esterline; our indebtedness;
potential environmental liabilities; liabilities arising in connection with
litigation; increases in raw material costs, taxes and labor costs that cannot
be recovered in product pricing; risks and costs associated with our
international sales and operations; and other factors. Please refer to the other
information included in this Quarterly Report on Form 10-Q and to Item 1A of the
Annual Report on Form 10-K for additional information regarding the foregoing
factors that may affect our business.
Overview
We believe we are a leading global designer, producer and supplier of highly
engineered aircraft components for use on nearly every commercial and military
aircraft in service today. Our business is well diversified due to the broad
range of products we offer to our customers. Some of our more significant
product offerings, substantially all of which are ultimately provided to
end-users in the aerospace industry, include mechanical/electro-mechanical
actuators and controls, ignition systems and engine technology, specialized
pumps and valves, power conditioning devices, specialized AC/DC electric motors
and generators, NiCad batteries and chargers, engineered latching and locking
devices, rods and locking devices, engineered connectors and elastomers, databus
and power controls, cockpit security components and systems, specialized cockpit
displays, aircraft audio systems, specialized lavatory components, seat belts
and safety restraints, engineered interior surfaces and related components,
advanced sensor products, switches and relay panels, advanced displays, thermal
protection and insulation, lighting and control technology, military personnel
parachutes, high performance hoists, winches and lifting devices, and cargo
loading, handling and delivery systems. Each of these product offerings is
composed of many individual products that are typically customized to meet the
needs of a particular aircraft platform or customer.
For the second quarter of fiscal year 2020, we generated net sales of $1,443
million and net income attributable to TD Group of $319 million. This included
net income from continuing operations attributable to TD Group of $323 million
and loss from discontinued operations, net of tax, of $4 million. EBITDA As
Defined was $675 million, or 46.8% of net sales. See the "Non-GAAP Financial
Measures" section for certain information regarding EBITDA and EBITDA As
Defined, including reconciliations of EBITDA and EBITDA As Defined to net income
and net cash provided by operating activities.

                                       36

--------------------------------------------------------------------------------

Table of Contents



In December 2019, a novel strain of coronavirus ("COVID-19") surfaced in Wuhan,
China, and has since spread to other countries, including the United States. In
March 2020, the World Health Organization characterized COVID-19 as a pandemic.
The pandemic has resulted in governments around the world implementing
increasingly stringent measures to help control the spread of the virus,
including quarantines, "shelter in place" and "stay at home" orders, travel
restrictions, business curtailments and other measures. In addition, governments
and central banks in several parts of the world have enacted fiscal and monetary
stimulus measures to counteract the impacts of COVID-19. The airline industry,
in particular, has been significantly disrupted, both domestically and
internationally.
Our results for the second quarter of fiscal 2020 were modestly adversely
impacted by decreases in sales in our commercial aftermarket and commercial OEM
channels during approximately the last three weeks of the second quarter of
fiscal 2020 due to the impact of the COVID-19 pandemic on our non-defense
customers and their demand for our products and services. Because the duration
and severity of the pandemic is uncertain at this time, it is difficult to
forecast any precise impact on the Company's future results. However, the
Company currently expects the COVID-19 pandemic to have a significant adverse
impact on our sales, net income and EBITDA as Defined for the remainder of
fiscal 2020 under the assumption that the COVID-19 pandemic will adversely
affect our non-defense customers and their demand for our products and services,
particularly in the commercial aftermarket. Longer term, the impact of the
COVID-19 pandemic is fluid and continues to evolve, and because both the
duration and severity of the outbreak are unclear, it is difficult to forecast
any precise impact on the Company's future results.
Beginning in the third quarter of fiscal 2020, as part of the Company's response
to the impact of the COVID-19 pandemic on its business, the Company is taking
cost reduction measures such as: (1) reducing its workforce by up to 15% to
align operations with customer demand. These actions are in addition to the cost
mitigation efforts implemented earlier this calendar year in response to the 737
MAX production rate changes; (2) implementing one to eight-week unpaid furloughs
at many businesses over approximately the next six months in response to
business specific situations; (3) TransDigm's senior management team will
substantially reduce their cash compensation for the balance of fiscal 2020; (4)
members of TransDigm's Board of Directors will forgo their annual retainer fees;
and, (5) the Company has reassessed capital expenditure projects planned and are
prioritizing only those projects that are deemed essential in the near term.
The Company continues to analyze its cost structure and may implement additional
cost reduction measures as may be necessary due to the ongoing business
challenges resulting from the COVID-19 pandemic. The impact of the COVID-19
pandemic is fluid and continues to evolve, and therefore, we cannot currently
predict the extent to which our business, results of operations, financial
condition or liquidity will ultimately be impacted.
Within the United States, our business has been designated an essential
business, which allows us to continue to serve our customers, however, the
COVID-19 pandemic has also disrupted our operations. The outbreak of COVID-19
has heightened the risk that a significant portion of our workforce will suffer
illness or otherwise be unable to work. Furthermore, in light of our
determination that planned reductions in our workforce will be necessary as a
result of declines in our business caused by the COVID-19 pandemic, we cannot
assure that we will be able to rehire our workforce once our business has
recovered. Certain of our facilities have experienced temporary disruptions as a
result of the COVID-19 pandemic, and we cannot predict whether our facilities
will experience more significant disruptions in the future. Finally, our
acquisition strategy, which is a key element of our overall business strategy,
may be impacted by our efforts to maintain the Company's liquidity position in
response to the COVID-19 pandemic.
Critical Accounting Policies and Estimates
The preparation and fair presentation of the consolidated unaudited interim
financial statements and accompanying notes included in this report are the
responsibility of management. The financial statements and footnotes have been
prepared in accordance with U.S. generally accepted accounting principles for
interim financial statements and contain certain amounts that were based upon
management's best estimates, judgments and assumptions that were believed to be
reasonable under the circumstances. On an ongoing basis, we evaluate the
accounting policies and estimates used to prepare financial statements.
Estimates are based on historical experience, judgments and assumptions believed
to be reasonable under current facts and circumstances. Actual amounts and
results could differ from these estimates used by management.
A comprehensive discussion of the Company's critical accounting policies and
management estimates and significant accounting policies followed in the
preparation of the financial statements is included in Item 7 of our Annual
Report on Form 10-K for the fiscal year ended September 30, 2019. Other than the
adoption of ASC 842, "Leases," there have been no significant changes in
critical accounting policies, management estimates or accounting policies since
the fiscal year ended September 30, 2019. Refer to Note 4, "Recent Accounting
Pronouncements," and Note 16, "Leases," for further information of accounting
standards recently adopted or required to be adopted in the future.
Acquisitions and Divestitures
Recent acquisitions and divestitures are described in Note 3, "Acquisitions and
Divestitures," to the condensed consolidated financial statements.

                                       37

--------------------------------------------------------------------------------

Table of Contents



Results of Operations
The following table sets forth, for the periods indicated, certain operating
data of the Company, including presentation of the amounts as a percentage of
net sales (amounts in millions):
                                                           Thirteen Week Periods Ended
                                         March 28, 2020    % of Sales      March 30, 2019     % of Sales
Net sales                               $       1,443         100.0  %   $          1,168         100.0 %
Cost of sales                                     625          43.3  %                518          44.3 %
Selling and administrative expenses               180          12.5  %                160          13.7 %
Amortization of intangible assets                  46           3.2  %                 22           1.9 %
Income from operations                            592          41.0  %                468          40.1 %
Interest expense, net                             252          17.5  %                202          17.3 %
Refinancing costs                                   3           0.2  %                  3           0.3 %
Income tax provision                               14           1.0  %                 63           5.4 %
Income from continuing operations                 323          22.4  %                200          17.1 %
Less: Net income attributable to
noncontrolling interests                            -             -  %                  -             - %
Income from continuing operations
attributable to TD Group                          323          22.4  %                200          17.1 %
(Loss) Income from discontinued
operations, net of tax                             (4 )        (0.3 )%                  2           0.2 %

Net income attributable to TD Group $ 319 22.1 % $


          202          17.3 %


                                                          Twenty-Six Week Periods Ended
                                         March 28, 2020    % of Sales      March 30, 2019     % of Sales
Net sales                               $       2,908         100.0  %   $          2,161         100.0 %
Cost of sales                                   1,288          44.3  %                947          43.8 %
Selling and administrative expenses               381          13.1  %                282          13.0 %
Amortization of intangible assets                  86           3.0  %                 42           1.9 %
Income from operations                          1,153          39.6  %                890          41.2 %
Interest expense, net                             501          17.2  %                374          17.3 %
Refinancing costs                                  26           0.9  %                  3           0.1 %
Other income                                       (3 )        (0.1 )%                  -             - %
Income tax provision                               73           2.5  %                117           5.4 %
Income from continuing operations                 556          19.1  %                396          18.3 %
Less: Net income attributable to
noncontrolling interests                           (1 )           -  %                  -             - %
Income from continuing operations
attributable to TD Group                          555          19.1  %                396          18.3 %
Income from discontinued operations,
net of tax                                         68           2.3  %                  2           0.1 %

Net income attributable to TD Group $ 623 21.4 % $


          398          18.4 %



                                       38

--------------------------------------------------------------------------------

Table of Contents



Changes in Results of Operations
Thirteen week period ended March 28, 2020 compared with the thirteen week period
ended March 30, 2019
Total CompanyNet Sales. Net organic sales and acquisition sales and the related dollar and

percentage changes for the thirteen week periods ended March 28, 2020 and

March 30, 2019 were as follows (amounts in millions):


                                          Thirteen Week Periods Ended                            % Change
                                      March 28, 2020       March 30, 2019        Change        Total  Sales
Organic sales                        $         1,128     $          1,072     $        56            4.8 %
Acquisition sales                                315                   96             219           18.8 %
                                     $         1,443     $          1,168     $       275           23.5 %


The increase in organic sales for the thirteen week period ended March 28, 2020
compared to the thirteen week period ended March 30, 2019, is primarily related
to an increase in defense sales ($31 million, an increase of 7.3%), commercial
OEM sales ($18 million, an increase of 5.9%) and commercial aftermarket sales
($2 million, an increase of 0.6%).
Acquisition sales represent sales of acquired businesses for the period up to
one year subsequent to their respective acquisition date. The acquisition sales
in the table above for the thirteen week periods ended March 28, 2020 and March
30, 2019 were attributable to the sales recorded by the Esterline businesses
acquired by TransDigm in March 2019 for the thirteen week periods ended March
28, 2020 and March 30, 2019. For the quarter ended March 28, 2020, the
businesses acquired through the Esterline acquisition generated total sales of
$372 million. As TransDigm completed the acquisition of Esterline on March 14,
2019, the amount attributed to Acquisition sales in the table above has been
adjusted to reflect eleven weeks of sales from the Esterline businesses during
the thirteen week period ended March 28, 2020. These eleven weeks of sales
represent the incremental sales not captured in the comparable quarter of the
prior year period arising from TransDigm's acquisition of Esterline.
•   Cost of Sales and Gross Profit. Cost of sales increased by $107 million, or

20.7%, to $625 million for the thirteen week period ended March 28, 2020

compared to $518 million for the thirteen week period ended March 30, 2019.

Cost of sales and the related percentage of total sales for the thirteen week


    periods ended March 28, 2020 and March 30, 2019 were as follows (amounts in
    millions):


                                                   Thirteen Week Periods Ended
                                               March 28, 2020        March 30, 2019        Change        % Change
Cost of sales - excluding costs below        $        646           $          502      $       144         28.7  %
% of total sales                                     44.8  %                  43.0  %
Acquisition integration costs                           2                        1                1        100.0  %
% of total sales                                      0.1  %                   0.1  %
Stock compensation expense                              1                        2               (1 )      (50.0 )%
% of total sales                                      0.1  %                   0.2  %
Inventory acquisition accounting adjustments            -                       16              (16 )     (100.0 )%
% of total sales                                        -  %                   1.4  %
Loss contract amortization                            (11 )                     (2 )             (9 )     (450.0 )%
% of total sales                                     (0.8 )%                  (0.2 )%
Foreign currency gain                                 (13 )                     (1 )            (12 )   (1,200.0 )%
% of total sales                                     (0.9 )%                  (0.1 )%
Total cost of sales                          $        625           $          518      $       107         20.7  %
% of total sales                                     43.3  %                  44.3  %
Gross profit                                 $        818           $          650      $       168         25.8  %
Gross profit percentage                              56.7  %                  55.7  %


The increase in the dollar amount of cost of sales during the thirteen week
period ended March 28, 2020 was primarily due to increased sales volume as a
result of the Esterline businesses acquired in March 2019. This was slightly
offset by a decrease in inventory acquisition accounting costs as they were
fully amortized by fiscal 2020, foreign currency gains and amortization of loss
contract reserves primarily related to the Esterline businesses.

                                       39

--------------------------------------------------------------------------------

Table of Contents



Gross profit as a percentage of sales increased by 1.0 percentage point to 56.7%
for the thirteen week period ended March 28, 2020 from 55.7% for the thirteen
week period ended March 30, 2019. This increase was driven by the application of
our three core value-driven operating strategies (obtaining profitable new
business, continually improving our cost structure, and providing highly
engineered value-added products to customers). Although gross profit as a
percentage of sales continues to improve for the Esterline businesses as the
integration activities continue, the gross profits earned by the Esterline
businesses have a dilutive effect on TransDigm's gross profit percentage for the
thirteen week period ended March 28, 2020.
•   Selling and Administrative Expenses. Selling and administrative expenses

increased by $20 million to $180 million, or 12.5% of sales, for the thirteen

week period ended March 28, 2020 from $160 million, or 13.7% of sales, for

the thirteen week period ended March 30, 2019. Selling and administrative

expenses and the related percentage of total sales for the thirteen week


    periods ended March 28, 2020 and March 30, 2019 were as follows (amounts in
    millions):


                                             Thirteen Week Periods Ended
                                         March 28, 2020       March 30, 2019        Change        % Change
Selling and administrative expenses -
excluding costs below                   $        163         $           121     $        42         34.7  %
% of total sales                                11.3 %                  10.4 %
Stock compensation expense                        10                      18              (8 )      (44.4 )%
% of total sales                                 0.7 %                   1.5 %
Acquisition-related expenses                       7                      21             (14 )      (66.7 )%
% of total sales                                 0.5 %                   1.8 %
Total selling and administrative
expenses                                $        180         $           160     $        20         12.5  %
% of total sales                                12.5 %                  13.7 %


The increase in the dollar amount of selling and administrative expenses during
the thirteen week period ended March 28, 2020 is primarily due to increased
sales volume as a result of the Esterline businesses acquired in March 2019,
partially offset by decreases in acquisition-related expenses of $14 million and
stock compensation expense of $8 million. The decrease in stock compensation
expense is attributable to a cumulative adjustment to expense under US GAAP for
a change in the expected vesting percentage of the fiscal 2020 stock option
grants.
•    Amortization of Intangible Assets. Amortization of intangible assets was $46

million for the thirteen week period ended March 28, 2020 compared to $22

million in the thirteen week period ended March 30, 2019. The increase in

amortization expense of $24 million was due to the amortization expense on

the definite-lived intangible assets recorded in connection with the fiscal


     2019 acquisition of Esterline.


•    Refinancing Costs. Refinancing costs of $3 million were recorded for the

thirteen week period ended March 28, 2020 and primarily related to certain

fees incurred to refinance its term loans in February 2020.

• Interest Expense-net. Interest expense-net includes interest on borrowings

outstanding, amortization of debt issuance costs, original issue discount

and premium and revolving credit facility fees; slightly offset by interest

income. Interest expense-net increased $50 million, or 24.8%, to $252

million for the thirteen week period ended March 28, 2020 from $202 million

for the comparable thirteen week period last year. The net increase in

interest expense-net was primarily due to an increase in the weighted

average level of outstanding borrowings, which was approximately $18.5

billion for the thirteen week period ended March 28, 2020 and approximately

$15.3 billion for the thirteen week period ended March 30, 2019. The

increase in weighted average level of borrowings was primarily due to the

activity in the first and second quarter of fiscal 2020 consisting of the

issuance of $2.65 billion in 5.50% 2027 Notes and the $200 million draw on

the revolving credit facility. The increases in new debt described above

were slightly offset by the redemption of $1.15 billion in 6.00% 2022 Notes

in the first quarter of fiscal 2020. The weighted average interest rate for

cash interest payments on total borrowings outstanding for the thirteen week


     period ended March 28, 2020 was 5.31%.



                                       40

--------------------------------------------------------------------------------

Table of Contents

• Income Taxes. Income tax expense as a percentage of income before income

taxes was approximately 4.2% for the thirteen week period ended March 28,

2020 compared to 24.2% for the thirteen week period ended March 30, 2019. On

March 27, 2020, President Trump signed into law the CARES Act in response to

the COVID-19 pandemic. The CARES Act, among other things, includes

provisions relating to refundable payroll tax credits, deferment of employer

social security payments, net operating loss carryback periods, alternative

minimum tax credit refunds, and modifications to the net interest deduction

limitations. The most significant impact of the CARES Act for the Company is

an increase of the IRC 163(j) Interest Disallowance Limitations from 30% to

50% of adjusted taxable income which will allow the Company to deduct

additional interest for fiscal years 2020 (retroactive to October 1, 2019

for the Company) and 2021. The Company's lower effective tax rate for the

thirteen week period ended March 28, 2020 was primarily due to a discrete


     benefit recognized for excess tax benefits for share-based payments, in
     addition to the modification of the interest expense limitation under IRC

Section 163(j) enacted as part of the CARES Act. The Company's effective tax

rate for the thirteen week period ended March 28, 2020 was lower than the

Federal statutory rate of 21% primarily due to a discrete benefit recognized

for excess tax benefits for share-based payments, partially offset by

foreign earnings taxed at rates higher than the U.S. statutory rate.

• (Loss) Income from Discontinued Operations. Discontinued operations for the

thirteen week period ended March 28, 2020 includes an immaterial adjustment

of $4 million on the gain recognized from the sale of Souriau-Sunbank.

Discontinued operations for the thirteen week period ended March 30, 2019

include the results of the operations of the Souriau-Sunbank Connection

Technologies business and the Esterline Interface Technology ("EIT") group

of businesses. Both businesses were acquired by TransDigm as part of its

acquisition of Esterline in March 2019. On December 20, 2019, TransDigm

completed the divestiture of Souriau-Sunbank to Eaton Corporation plc

("Eaton") for approximately $920 million. On September 20, 2019, TransDigm

completed the divestiture of EIT to an affiliate of KPS Capital Partners, LP

for approximately $190 million.




Income from discontinued operations for the thirteen week period ended March 30,
2019 is $1 million and includes the results of operations of the Souriau-Sunbank
and EIT businesses.
•    Net Income Attributable to TD Group. Net income attributable to TD Group

increased $117 million, or 57.9%, to $319 million for the thirteen week

period ended March 28, 2020 compared to net income attributable to TD Group

of $202 million for the thirteen week period ended March 30, 2019, primarily

as a result of the factors referred to above.

• Earnings per Share. Basic and diluted earnings per share was $5.56 for the

thirteen week period ended March 28, 2020 and $3.60 per share for the

thirteen week period ended March 30, 2019. Basic and diluted earnings (loss)

per share from continuing operations and discontinued operations was $5.63


     and $(0.07), respectively, for the thirteen week period ended March 28,
     2020. Basic and diluted earnings per share from continuing operations and

discontinued operations was $3.56 and $0.04, respectively, for the thirteen

week period ended March 30, 2019.

Business Segments • Segment Net Sales. Net sales by segment for the thirteen week periods ended

March 28, 2020 and March 30, 2019 were as follows (amounts in millions):


                                       Thirteen Week Periods Ended
                     March 28, 2020     % of Sales      March 30, 2019     % of Sales       Change        % Change
Power & Control    $            747          51.8 %   $            631          54.0 %   $       116         18.4 %
Airframe                        655          45.4 %                499          42.7 %           156         31.3 %
Non-aviation                     41           2.8 %                 38           3.3 %             3          7.9 %
                   $          1,443         100.0 %   $          1,168         100.0 %   $       275         23.5 %


Acquisition sales for the Power & Control segment increased $70 million, or an
increase of 11.1%, resulting from the acquisition of Esterline. Organic sales
for the Power & Control segment increased $46 million, an increase of 7.3%, for
the thirteen week period ended March 28, 2020 compared to the thirteen week
period ended March 30, 2019. The organic sales increase resulted primarily from
an increase in commercial aftermarket sales ($16 million, an increase of 9.0%),
an increase in commercial OEM sales ($13 million, an increase of 9.5%) and an
increase in defense sales ($12 million, an increase of 4.0%).
Acquisition sales for the Airframe segment increased $146 million, or an
increase of 29.3%, resulting from the acquisition of Esterline. Organic sales
for the Airframe segment increased $10 million, an increase of 2.0%, for the
thirteen week period ended March 28, 2020 compared to the thirteen week period
ended March 30, 2019. The organic sales increase resulted primarily from an
increase in defense sales ($17 million, an increase of 13.8%) and commercial OEM
sales ($5 million, an increase of 3.1%); partially offset by a decrease in
commercial aftermarket sales ($14 million, a decrease of 6.9%).
Acquisition sales for the Non-aviation segment increased $3 million, or an
increase of 7.9%, resulting from the acquisition of Esterline.

                                       41

--------------------------------------------------------------------------------

Table of Contents

• EBITDA As Defined. EBITDA As Defined by segment for the thirteen week


     periods ended March 28, 2020 and March 30, 2019 were as follows (amounts in
     millions):


                                           Thirteen Week Periods Ended
                                          % of  Segment                          % of  Segment
                     March 28, 2020           Sales          March 30, 2019          Sales           Change        % Change
Power & Control    $        381                 55.2 %     $            329            56.3 %     $        52         15.8 %
Airframe                    296                 42.8 %                  243            41.6 %              53         21.8 %
Non-aviation                 14                  2.0 %                   12             2.1 %               2         16.7 %
                   $        691                100.0 %     $            584           100.0 %     $       107         18.3 %


EBITDA As Defined for the Power & Control segment from the acquisition of
Esterline increased approximately $20 million for the thirteen week period ended
March 28, 2020. Organic EBITDA As Defined for the Power & Control segment
increased approximately $32 million, an increase of 9.8%, resulting from organic
sales growth in defense, commercial OEM and commercial aftermarket, as well as
the application of our three core value-driven operating strategies, and
positive leverage on our fixed overhead costs spread over a higher production
volume.
EBITDA As Defined for the Airframe segment from the acquisition of Esterline
increased approximately $58 million for the thirteen week period ended March 28,
2020. Organic EBITDA as Defined for the Airframe segment decreased approximately
$5 million, a decrease of 1.9%, resulting from an organic sales decrease in the
commercial aftermarket, partially offset by organic sales increases in defense
and commercial OEM and the application of our three core value-driven operating
strategies.
EBITDA As Defined for the Non-aviation segment from the acquisition of Esterline
increased approximately $1 million for the thirteen week period ended March 28,
2020. Organic EBITDA As Defined for the Non-aviation segment increased
approximately $1 million, an increase of 9.2%.
Twenty-six week period ended March 28, 2020 compared with the twenty-six week
period ended March 30, 2019
Total CompanyNet Sales. Net organic sales and acquisition sales and the related dollar and

percentage changes for the twenty-six week periods ended March 28, 2020 and

March 30, 2019 were as follows (amounts in millions):


                                          Twenty-Six Week Periods Ended                           % Change
                                       March 28, 2020       March 30, 2019        Change        Total  Sales
Organic sales                        $          2,209     $          2,065     $       144            6.7 %
Acquisition sales                                 699                   96             603           27.9 %
                                     $          2,908     $          2,161     $       747           34.6 %


The increase in organic sales for the twenty-six week period ended March 28,
2020 compared to the twenty-six week period ended March 30, 2019, is primarily
related to an increase in defense sales ($74 million, an increase of 9.5%),
commercial aftermarket sales ($45 million, an increase of 6.3%) and commercial
OEM sales ($17 million, an increase of 3.0%).
Acquisition sales represent sales of acquired businesses for the period up to
one year subsequent to their respective acquisition date. The acquisition sales
in the table above for the twenty-six week periods ended March 28, 2020 and
March 30, 2019 were attributable to the sales recorded by the Esterline
businesses acquired by TransDigm in March 2019 for the twenty-six week periods
ended March 28, 2020 and March 30, 2019. For the twenty-six week period ended
March 28, 2020, the businesses acquired through the Esterline acquisition
generated total sales of $756 million. As TransDigm completed the acquisition of
Esterline on March 14, 2019, the amount attributed to Acquisition sales in the
table above has been adjusted to reflect twenty-four weeks of sales from the
Esterline businesses during the twenty-six week period ended March 28, 2020.
These twenty-four weeks of sales represent the incremental sales not captured in
the comparable twenty-six week period of the prior year period arising from
TransDigm's acquisition of Esterline.

                                       42

--------------------------------------------------------------------------------

Table of Contents

• Cost of Sales and Gross Profit. Cost of sales increased by $341 million, or

36.0%, to $1,288 million for the twenty-six week period ended March 28, 2020

compared to $947 million for the twenty-six week period ended March 30, 2019.

Cost of sales and the related percentage of total sales for the twenty-six


    week periods ended March 28, 2020 and March 30, 2019 were as follows (amounts
    in millions):


                                                 Twenty-Six Week Periods Ended
                                              March 28, 2020       March 30, 2019       Change        % Change
Cost of sales - excluding costs below        $      1,305         $         928      $       377         40.6  %
% of total sales                                     44.9  %               42.9  %
Stock compensation expense                              4                     4                -            -  %
% of total sales                                      0.1  %                0.2  %
Acquisition integration costs                           3                     3                -            -  %
% of total sales                                      0.1  %                0.1  %
Foreign currency loss (gain)                            1                    (3 )              4        133.3  %
% of total sales                                        -  %               (0.1 )%
Inventory acquisition accounting adjustments            -                    20              (20 )     (100.0 )%
% of total sales                                        -  %                0.9  %
Loss contract amortization                            (25 )                  (5 )            (20 )     (400.0 )%
% of total sales                                     (0.9 )%               (0.2 )%
Total cost of sales                          $      1,288         $         947      $       341         36.0  %
% of total sales                                     44.3  %               43.8  %
Gross profit                                 $      1,620         $       1,214      $       406         33.4  %
Gross profit percentage                              55.7  %               56.2  %


The increase in the dollar amount of cost of sales during the twenty-six week
period ended March 28, 2020 was primarily due to increased sales volume as a
result of the Esterline businesses acquired in March 2019 compared to the
twenty-six week period ended March 30, 2019. This was slightly offset by a
decrease in inventory acquisition accounting adjustments as they were fully
amortized prior to fiscal 2020 and amortization of loss contract reserves
primarily related to the Esterline acquisition.
Gross profit as a percentage of sales decreased by 0.5 points to 55.7% for the
twenty-six week period ended March 28, 2020 from 56.2% for the twenty-six week
period ended March 30, 2019. The decrease in the gross profit percentage is
primarily driven by the dilutive effect of the Esterline businesses on the gross
profit percentage for the twenty-six week period ended March 28, 2020. However,
the gross profit percentage continues to improve for the Esterline businesses as
integration activities continue including the application of our three core
value-driven operating strategies (obtaining profitable new business,
continually improving our cost structure, and providing highly engineered
value-added products to customers).
•   Selling and Administrative Expenses. Selling and administrative expenses

increased by $99 million to $381 million, or 13.1% of sales, for the

twenty-six week period ended March 28, 2020 from $282 million, or 13.1% of

sales, for the twenty-six week period ended March 30, 2019. Selling and

administrative expenses and the related percentage of total sales for the


    twenty-six week periods ended March 28, 2020 and March 30, 2019 were as
    follows (amounts in millions):


                                            Twenty-Six Week Periods Ended
                                         March 28, 2020       March 30, 2019        Change        % Change
Selling and administrative expenses -
excluding costs below                   $        335         $           221     $       114         51.6  %
% of total sales                                11.5 %                  10.2 %
Stock compensation expense                        33                      34              (1 )       (2.9 )%
% of total sales                                 1.1 %                   1.6 %
Acquisition-related expenses                      13                      27             (14 )      (51.9 )%
% of total sales                                 0.4 %                   1.2 %
Total selling and administrative
expenses                                $        381         $           282     $        99         35.1  %
% of total sales                                13.1 %                  13.1 %



                                       43

--------------------------------------------------------------------------------

Table of Contents



The increase in the dollar amount of selling and administrative expenses during
the twenty-six week period ended March 28, 2020 is primarily due to increased
sales volume as a result of the Esterline businesses acquired in March 2019,
partially offset by decreases in acquisition-related expenses of $14 million and
stock compensation expense of $1 million. The decrease in stock compensation
expense is attributable to a cumulative adjustment to expense under US GAAP
recorded in the second quarter of fiscal 2020 for a change in the expected
vesting percentage of the fiscal 2020 stock option grants.
•    Amortization of Intangible Assets. Amortization of intangible assets was $86

million for the twenty-six week period ended March 28, 2020 compared to $42

million in the twenty-six week period ended March 30, 2019. The increase in

amortization expense of $44 million was due to the amortization expense on

the definite-lived intangible assets recorded in connection with the fiscal

2019 acquisition of Esterline.

• Refinancing Costs. Refinancing costs of $26 million were recorded for the

twenty-six week period ended March 28, 2020 and primarily related to the

fees incurred on the redemption of the 2022 Notes that occurred in the first

quarter of fiscal 2020 and certain fees incurred to refinance the term loans

in the second quarter of fiscal 2020.

• Other Income. Other income of $3 million was recorded for the twenty-six

week period ended March 28, 2020 and primarily related to the non-service

related components of net periodic benefit costs on the Company's defined

benefit pension plans.

• Interest Expense-net. Interest expense-net includes interest on borrowings

outstanding, amortization of debt issuance costs, original issue discount

and premium and revolving credit facility fees slightly offset by interest


     income. Interest expense-net increased $127 million, or 34.0%, to $501
     million for the twenty-six week period ended March 28, 2020 from $374
     million for the comparable twenty-six week period last year. The net
     increase in interest expense-net was primarily due to an increase in the

weighted average level of outstanding borrowings, which was approximately

$18.2 billion for the twenty-six week period ended March 28, 2020 and

approximately $14.1 billion for the twenty-six week period ended March 30,

2019. The increase in weighted average level of borrowings was primarily due

to the activity in the second quarter of fiscal 2019 consisting of the

issuance of $4.0 billion in 6.25% 2026 Secured Notes and the issuance of

$550 million in 7.50% 2027 Notes and the activity in the first and second

quarters of fiscal 2020 consisting of the issuance of $2.65 billion in 5.50%

2027 Notes and the $200 million draw on the revolving credit facility. The

increases in new debt described above were slightly offset by the

redemptions of $550 million in 5.50% 2020 Notes and $1.15 billion in 6.00%

2022 Notes. The weighted average interest rate for cash interest payments on

total borrowings outstanding for the twenty-six week period ended March 28,

2020 was 5.20%.

• Income Taxes. Income tax expense as a percentage of income before income

taxes was approximately 11.6% for the twenty-six week period ended March 28,

2020 compared to 22.9% for the twenty-six week period ended March 30, 2019.

On March 27, 2020, President Trump signed into law the CARES Act in response

to the COVID-19 pandemic. The CARES Act, among other things, includes

provisions relating to refundable payroll tax credits, deferment of employer

social security payments, net operating loss carryback periods, alternative

minimum tax credit refunds, and modifications to the net interest deduction

limitations. The most significant impact of the CARES Act for the Company is

an increase of the IRC 163(j) Interest Disallowance Limitations from 30% to

50% of adjusted taxable income which will allow the Company to deduct

additional interest for fiscal years 2020 and 2021. The Company's lower


     effective tax rate for the twenty-six week period ended March 28, 2020 was
     primarily due to a discrete benefit recognized for excess tax benefits for
     share-based payments, in addition to the modification of the interest

expense limitation under IRC Section 163(j) enacted as part of the CARES

Act. The Company's effective tax rate for the period ended March 28, 2020

was lower than the Federal statutory rate of 21% primarily due to a discrete

benefit recognized for excess tax benefits for share-based payments,

partially offset by foreign earnings taxed at rates higher than the U.S.

statutory rate.

• Income from Discontinued Operations. Discontinued operations for the

twenty-six week period ended March 28, 2020 include the results of the

operations of Souriau-Sunbank. Discontinued operations for the twenty-six


     week period ended March 30, 2019 include the results of the operations of
     Souriau-Sunbank and the Esterline Interface Technology ("EIT") group of
     businesses. Both businesses were acquired by TransDigm as part of its

acquisition of Esterline in March 2019. On December 20, 2019, TransDigm

completed the divestiture of Souriau-Sunbank to Eaton for approximately $920

million. On September 20, 2019, TransDigm completed the divestiture of EIT

to an affiliate of KPS Capital Partners, LP for approximately $190 million.




Income from discontinued operations for the twenty-six week period ended
March 28, 2020 is $68 million and includes $8 million from Souriau-Sunbank's
operations and a gain on the sale of Souriau-Sunbank, net of tax, of $60
million. Income from discontinued operations for the twenty-six week period
ended March 30, 2019 is $1 million and includes the results of operations of the
Souriau-Sunbank and EIT businesses.
•    Net Income Attributable to TD Group. Net income attributable to TD Group

increased $225 million, or 56.5%, to $623 million for the twenty-six week

period ended March 28, 2020 compared to net income attributable to TD Group


     of $398 million for the twenty-six week period ended March 30, 2019,
     primarily as a result of the factors referred to above.



                                       44

--------------------------------------------------------------------------------

Table of Contents

• Earnings per Share. Basic and diluted earnings per share was $7.63 for the

twenty-six week period ended March 28, 2020 and $6.65 per share for the

twenty-six week period ended March 30, 2019. Basic and diluted earnings per

share from continuing operations and discontinued operations was $6.45 and

$1.18, respectively, for the twenty-six week period ended March 28, 2020.

Basic and diluted earnings per share from continuing operations and

discontinued operations was $6.61 and $0.04, respectively, for the

twenty-six week period ended March 30, 2019. Net income attributable to TD

Group for the twenty-six week period ended March 28, 2020 of $623 million

was decreased by dividend equivalent payments paid of $185 million, or $3.22

per share, resulting in net income available to common shareholders of $438

million, or $7.63 per share. Net income for the twenty-six week period ended

March 30, 2019 of $398 million was decreased by dividend equivalent payments


     of $24 million, or $0.43 per share, resulting in net income available to
     common shareholders of $374 million, or $6.65 per share.

Business Segments • Segment Net Sales. Net sales by segment for the twenty-six week periods


     ended March 28, 2020 and March 30, 2019 were as follows (amounts in
     millions):


                                      Twenty-Six Week Periods Ended
                     March 28, 2020     % of Sales      March 30, 2019    

% of Sales       Change        % Change
Power & Control    $          1,499          51.5 %   $          1,192          55.2 %   $       307         25.8 %
Airframe                      1,329          45.7 %                898          41.5 %           431         48.0 %
Non-aviation                     80           2.8 %                 71           3.3 %             9         12.7 %
                   $          2,908         100.0 %   $          2,161         100.0 %   $       747         34.6 %


Acquisition sales for the Power & Control segment increased $196 million, or an
increase of 16.4%, resulting from the acquisition of Esterline. Organic sales
for the Power & Control segment increased $111 million, an increase of 9.3%, for
the twenty-six week period ended March 28, 2020 compared to the twenty-six week
period ended March 30, 2019. The organic sales increase resulted primarily from
an increase in defense sales ($50 million, an increase of 8.7%), an increase in
commercial aftermarket sales ($45 million, an increase of 13.4%) and an increase
in commercial OEM sales ($10 million, an increase of 4.0%).
Acquisition sales for the Airframe segment increased $401 million, or an
increase of 44.7%, resulting from the acquisition of Esterline. Organic sales
for the Airframe segment increased $30 million, an increase of 3.3%, for the
twenty-six week period ended March 28, 2020 compared to the twenty-six week
period ended March 30, 2019. The organic sales increase resulted primarily from
an increase in defense sales ($22 million, an increase of 10.5%) and commercial
OEM sales ($6 million, an increase of 2.1%).
Acquisition sales for the Non-aviation segment increased $7 million, or an
increase of 9.9%, resulting from the acquisition of Esterline. Organic sales for
the Non-aviation segment increased by $2 million, an increase of 2.8%, for the
twenty-six week period ended March 28, 2020 compared to the twenty-six week
period ended March 30, 2019.
•    EBITDA As Defined. EBITDA As Defined by segment for the twenty-six week
     periods ended March 28, 2020 and March 30, 2019 were as follows (amounts in
     millions):


                                          Twenty-Six Week Periods Ended
                                         % of  Segment                          % of  Segment
                     March 28, 2020          Sales          March 30, 2019          Sales           Change        % Change
Power & Control    $            766            54.9 %     $            628            58.0 %     $       138         22.0 %
Airframe                        602            43.2 %                  434            40.0 %             168         38.7 %
Non-aviation                     26             1.9 %                   22             2.0 %               4         18.2 %
                   $          1,394           100.0 %     $          1,084           100.0 %     $       310         28.6 %


EBITDA As Defined for the Power & Control segment from the acquisition of
Esterline increased approximately $55 million for the twenty-six week period
ended March 28, 2020. Organic EBITDA As Defined for the Power & Control segment
increased approximately $83 million, an increase of 13.2%, resulting from
organic sales growth in defense, commercial OEM and commercial aftermarket, as
well as the application of our three core value-driven operating strategies, and
positive leverage on our fixed overhead costs spread over a higher production
volume.
EBITDA As Defined for the Airframe segment from the acquisition of Esterline
increased approximately $153 million for the twenty-six week period ended
March 28, 2020. Organic EBITDA as Defined for the Airframe segment increased
approximately $15 million, an increase of 3.5%, primarily resulting from organic
sales growth in defense and commercial OEM as well as the application of our
three core value-driven operating strategies.

                                       45

--------------------------------------------------------------------------------

Table of Contents



EBITDA As Defined for the Non-aviation segment from the acquisition of Esterline
increased approximately $1 million for the twenty-six week period ended
March 28, 2020. Organic EBITDA As Defined for the Non-aviation segment increased
approximately $3 million, an increase of 13.6%.
Backlog
As of March 28, 2020, the Company estimated its sales order backlog at $3,540
million compared to $2,188 million as of March 30, 2019. The sales order backlog
associated with the acquired Esterline businesses was excluded in the sales
order backlog total as of March 30, 2019 as at the time it was being assessed by
TransDigm management to ensure the reported backlog was in compliance with
TransDigm policy and computed consistently with that of the existing TransDigm
legacy businesses.
Excluding the increase in the sales order backlog attributable to the Esterline
businesses being included in the total as of March 28, 2020, backlog increased
approximately $70 million compared to March 30, 2019. The majority of the
purchase orders outstanding as of March 28, 2020 are scheduled for delivery
within the next twelve months. Purchase orders may be subject to cancellation or
deferral by the customer prior to shipment. The level of unfilled purchase
orders at any given date during the year will be materially affected by the
timing of the Company's receipt of purchase orders and the speed with which
those orders are filled. Accordingly, the Company's backlog as of March 28, 2020
may not necessarily represent the actual amount of shipments or sales for any
future period.
Foreign Operations
Although we manufacture a significant portion of our products in the United
States, we manufacture certain products in Europe, Asia, Canada, Mexico and
other countries globally. We sell our products in the United States as well as
in foreign countries. Although the majority of sales of our products are made to
customers (including distributors) located in the United States, our products
are ultimately sold to and used by customers, including airlines and other end
users of aircraft, throughout the world. A number of risks inherent in
international operations could have a material adverse effect on our results of
operations, including the COVID-19 pandemic, currency fluctuations, difficulties
in staffing and managing multi-national operations, general economic and
political uncertainties and potential for social unrest in countries in which we
operate, limitations on our ability to enforce legal rights and remedies,
restrictions on the repatriation of funds, change in trade policies, tariff
regulation, difficulties in obtaining export and import licenses and the risk of
government financed competition.
There can be no assurance that foreign governments will not adopt regulations or
take other action that would have a direct or indirect adverse impact on the
business or market opportunities of the Company within such governments'
countries. Furthermore, there can be no assurance that the political, cultural
and economic climate outside the United States will be favorable to our
operations and growth strategy.
Liquidity and Capital Resources
We have historically maintained a capital structure comprising a mix of equity
and debt financing. We vary our leverage both to optimize our equity return and
to pursue acquisitions. We expect to meet our current debt obligations as they
come due through internally generated funds from current levels of operations
and/or through refinancing in the debt markets prior to the maturity dates of
our debt.
We continually evaluate our debt facilities to assess whether they most
efficiently and effectively meet the current and future needs of our business.
The Company evaluates from time to time the appropriateness of its current
leverage, taking into consideration the Company's debt holders, equity holders,
credit ratings, acquisition opportunities and other factors.
If the Company has excess cash, it generally prioritizes allocating the excess
cash in the following manner: (1) capital spending at existing businesses, (2)
acquisitions of businesses, (3) payment of a special dividend and/or repurchases
of our common stock and (4) prepayment of indebtedness or repurchase of debt.
Whether the Company undertakes common stock repurchases or other aforementioned
activities will depend on prevailing market conditions, the Company's liquidity
requirements, contractual restrictions and other factors. The amounts involved
may be material. In addition, the Company may issue additional debt if
prevailing market conditions are favorable to doing so.
The Company's ability to make scheduled interest payments on, or to refinance,
the Company's indebtedness, or to fund non-acquisition related capital
expenditures and research and development efforts, will depend on the Company's
ability to generate cash in the future. This is subject to general economic,
financial, competitive, legislative, regulatory and other factors that are
beyond its control, including the ongoing COVID-19 pandemic.
As TransDigm cannot predict the duration or scope of the COVID-19 pandemic and
its impact on our customers and suppliers, the potential negative financial
impact to its results cannot be reasonably estimated, but could be material. The
Company is actively managing the business to maintain cash flow, including the
cost reduction efforts described in Note 20, "Subsequent Events," to the
condensed consolidated financial statements in response to the COVID-19 pandemic
and are continuing to focus on the application of its three core value-driven
operating strategies (obtaining profitable new business, continually improving
its cost structure and providing highly engineered value-added products to
customers).

                                       46

--------------------------------------------------------------------------------

Table of Contents



In March 2020, the President of the United States signed the CARES Act, a
substantial tax-and-spending package intended to provide additional economic
stimulus to address the impact of the COVID-19 pandemic. The CARES Act, among
other things, includes provisions relating to refundable payroll tax credits,
deferment of employer social security payments, net operating loss carryback
periods, alternative minimum tax credit refunds, and modifications to the net
interest deduction limitations. The most significant impact of the CARES Act for
the Company is an increase of the IRC 163(j) Interest Disallowance Limitations
from 30% to 50% of adjusted taxable income which will allow the Company to
deduct additional interest for fiscal years 2020 and 2021. The Company continues
to assess the impact of the CARES Act and ongoing government guidance related to
COVID-19 that may be issued.
In March 2020, the Company drew $200 million on its revolving credit facility to
increase the Company's liquidity as a precautionary response to macroeconomic
conditions caused by the COVID-19 pandemic. Also, in further actions to increase
the Company's liquidity, the Company executed two notes offerings in April 2020
in which the proceeds received are for general Corporate purposes. On April 8,
2020, the Company entered into a purchase agreement in connection with a private
offering of $1,100 million in aggregate principal amount of 8.00% Senior Secured
Notes due 2025 at an issue price of 100% of the principal amount. On April 17,
2020, the Company entered into a purchase agreement in connection with a private
offering of $400 million in aggregate principal amount of 6.25% Senior Secured
Notes due 2026 at an issue price of 101% of the principal amount.
As of March 28, 2020, the Company has significant liquidity as illustrated in
the table presented below (in millions):
                                             As of March 28, 2020
Cash and cash equivalents                   $                2,668
Availability on revolving credit facility                      518
Liquidity (1)                               $                3,186



(1)   Excludes approximately $1,500 million in cash received from the April 2020
      secured notes offerings.


We believe our significant liquidity will allow us to meet our anticipated
funding requirements. We expect to meet our short-term liquidity requirements
(including interest obligations and capital expenditures) through net cash from
operating activities, cash on hand and, if needed, additional draws on the
revolving credit facility. Long-term liquidity requirements consist primarily of
obligations under our long-term debt agreements. There is no maturity on any
tranche of term loans or notes until July 2024. The Company's $350 million trade
receivable securitization facility renews annually in July.
Operating Activities. The Company generated $594 million of net cash from
operating activities during the twenty-six week period ended March 28, 2020
compared to $453 million during the twenty-six week period ended March 30, 2019.
The increase is primarily attributable to the additional net operating cash
inflows generated by the Esterline businesses.
The change in accounts receivable during the twenty-six week period ended
March 28, 2020 was a source of cash of $74 million compared to a use of cash of
$7 million during the twenty-six week period ended March 30, 2019. The increase
in the source of cash of $81 million is primarily attributable to the timing of
receipt of payment from customers as well as a slowdown in sales within the last
few weeks of the second fiscal quarter due to the COVID-19 pandemic.
The change in inventories during the twenty-six week period ended March 28, 2020
was a use of cash of $97 million compared to a use of cash of $45 million during
the twenty-six week period ended March 30, 2019. The increase in the use of cash
is primarily driven by the slowdown in sales as a result of the COVID-19
pandemic, particularly within the last few weeks of the second fiscal quarter.
The change in accounts payable during the twenty-six week period ended March 28,
2020 was a use of cash of $12 million compared to a source of cash of $1 million
during the twenty-six week period ended March 30, 2019.
Investing Activities. Net cash provided by investing activities was $854 million
during the twenty-six week period ended March 28, 2020, consisting of proceeds
of $904 million from the divestiture of Souriau-Sunbank and partially offset by
capital expenditures of $50 million.
Net cash used in investing activities was $3,613 million during the twenty-six
week period ended March 30, 2019, consisting of capital expenditures of $44
million and payments for acquisitions, net of cash acquired, of $3,569 million
which is primarily comprised of the acquisition of Esterline for $3,536 million
and NavCom for $27 million.
Financing Activities. Net cash used by financing activities during the
twenty-six week period ended March 28, 2020 was $248 million. The use of cash
was primarily attributable to dividend equivalent payments of $1,928 million,
the redemption of the 2022 Notes outstanding for $1,168 million, the purchase of
treasury stock of $19 million and repayments on term loans of $19 million. The
use of cash was partially offset by $2,625 million in net proceeds from the
completion of the 2027 5.50% Notes offering, $200 million in proceeds from the
revolving credit facility and $69 million in proceeds from stock option
exercises.

                                       47

--------------------------------------------------------------------------------

Table of Contents



Net cash provided by financing activities during the twenty-six week period
ended March 30, 2019 was $3,915 million. The source of cash was primarily
attributable to $4,482 million in net proceeds from the completion of the 2026
Secured Notes and 2027 Notes offerings in the second quarter of fiscal 2019 and
$47 million in proceeds from stock option exercises. Sources were partially
offset by the cash tender and redemption of the 2020 Notes for $550 million,
repayments on term loans of $38 million and the payment of $24 million in
dividend equivalent payments.
Contractual Obligations
We have future obligations under various contracts relating to debt and interest
payments, finance and operating leases, pension and post-retirement benefit
plans and purchase obligations. During the twenty six week period ended
March 28, 2020, other than the debt financing transactions described below and
in Note 9, "Debt," to the condensed consolidated financial statements, there
were no material changes to these obligations as reported in our Annual Report
on Form 10-K for the fiscal year ended September 30, 2019.
Description of Senior Secured Term Loans and Indentures
Senior Secured Term Loans Facility
TransDigm has $7,505 million in fully drawn term loans (the "Term Loans
Facility") and a $760 million revolving credit facility, on which the Company
drew approximately $200 million on March 24, 2020. The Term Loans Facility
consists of three tranches of term loans as follows (aggregate principal amount
disclosed is as of March 28, 2020):
Term Loans Facility   Aggregate Principal    Maturity Date       Interest Rate
     Tranche E          $2,216 million        May 30, 2025     LIBO rate + 2.25%
     Tranche F          $3,515 million      December 9, 2025   LIBO rate + 2.25%
     Tranche G          $1,774 million      August 22, 2024    LIBO rate + 2.25%


The Term Loans Facility requires quarterly aggregate principal payments of $18.8
million. The revolving commitments consist of two tranches which includes up to
$151.5 million of multicurrency revolving commitments. At March 28, 2020, the
Company had $41.7 million in letters of credit outstanding and $518.3 million in
borrowings available under the revolving commitments. The interest rates per
annum applicable to the loans under the Credit Agreement are, at TransDigm's
option, equal to either an alternate base rate or an adjusted LIBO rate for one,
two, three or six-month (or to the extent agreed to by each relevant lender,
nine or twelve-month) interest periods chosen by TransDigm, in each case plus an
applicable margin percentage. The adjusted LIBO rate related to the tranche E,
tranche F and tranche G term loans are not subject to a floor. For the
twenty-six week period ended March 28, 2020, the applicable interest rates
ranged from approximately 3.9% to 4.3% on the existing term loans. Interest rate
swaps and caps used to hedge and offset, respectively, the variable interest
rates on the credit facility are described in Note 12, "Derivatives and Hedging
Activities," to the condensed consolidated financial statements.
Recent Amendments to the Credit Agreement
On February 6, 2020, the Company entered into Amendment No. 7 and Refinancing
Facility Agreement (herein, "Amendment No. 7"). Under the terms of Amendment No.
7, the Company, among other things, (i) incurred new tranche E term loans in an
aggregate principal amount equal to approximately $2,216 million, new tranche F
term loans in an aggregate principal amount equal to approximately $3,515
million and new tranche G term loans, (collectively, the "New Term Loans") in an
aggregate principal amount equal to approximately $1,774 million, (ii) repaid in
full all of the existing tranche E term loans, tranche F term loans and tranche
G term loans outstanding under the Credit Agreement immediately prior to the
Amendment and (iii) extended the maturity date of the tranche F term loans to
December 9, 2025, (iv) modified the definition of consolidated EBITDA in the
Credit Agreement to add back certain cost savings and non-recurring cost and
expenses and (v) modified certain negative covenants to provide additional
flexibility to enable TransDigm to incur additional debt and make additional
investments and asset sales.
The New Term Loans were fully drawn on February 6, 2020. The LIBOR interest rate
per annum applicable to the New Term Loans is 2.25%, down from 2.50% prior to
the Amendment. The other terms and conditions that apply to the New Term Loans
are substantially the same as the terms and conditions that applied to the term
loans immediately prior to the Amendment.
On March 14, 2019, the Company entered into Amendment No. 6 to the Second
Amended and Restated Credit Agreement ("Amendment No. 6"). Under the terms of
Amendment No. 6, the capacity of the revolving credit facility increased from
$600 million to $760 million. The revolving credit facility consist of two
tranches which include up to $151.5 million of multicurrency revolving
commitments. The terms and conditions that apply to the revolving credit
facility, other than the additional revolving credit commitments, are
substantially the same as the terms and conditions that applied to the revolving
credit facility immediately prior to Amendment No. 6.

                                       48

--------------------------------------------------------------------------------

Table of Contents

Indentures

The following table represents the notes outstanding as of March 28, 2020:


   Description       Aggregate Principal     Maturity Date     Interest Rate
    2024 Notes         $1,200 million        July 15, 2024         6.50%
    2025 Notes          $750 million         May 15, 2025          6.50%
2026 Secured Notes     $4,000 million       March 15, 2026        6.250%
6.875% 2026 Notes       $500 million         May 15, 2026         6.875%
6.375% 2026 Notes       $950 million         June 15, 2026        6.375%
 7.50% 2027 Notes       $550 million        March 15, 2027         7.50%
 5.50% 2027 Notes      $2,650 million      November 15, 2027       5.50%


The 2024 Notes, the 6.375% 2026 Notes, the 7.50% 2027 Notes and the 5.50% 2027
Notes (the "TransDigm Inc. Notes") were issued at a price of 100% of the
principal amount. The initial $450 million offering of the 2025 Notes (also
considered to be part of the "TransDigm Inc. Notes") were issued at a price of
100% of the principal amount and the subsequent $300 million offering of 2025
Notes in the second quarter of fiscal 2017 were issued at a price of 101.5% of
the principal amount, resulting in gross proceeds of $304.5 million. The 6.875%
2026 Notes (the "TransDigm UK Notes" and together with the TransDigm Inc. Notes,
the "Notes," are further described below) offered in May 2018 were issued at a
price of 99.24% of the principal amount, resulting in gross proceeds of $496.2
million. The initial $3,800 million offering of the 2026 Secured Notes (the
"Secured Notes") were issued at a price of 100% of their principal amount and
the subsequent $200 million offering of the 2026 Secured Notes in the second
quarter of fiscal 2019 were issued at a price of 101% of their principal amount,
resulting in gross proceeds of $4,002 million.
The Notes do not require principal payments prior to their maturity. Interest
under the Notes is payable semi-annually. The Notes represent our unsecured
obligations ranking subordinate to our senior debt, as defined in the applicable
indentures.
The Notes are subordinated to all of our existing and future senior debt, rank
equally with all of our existing and future senior subordinated debt and rank
senior to all of our future debt that is expressly subordinated to the Notes.
The TransDigm Inc. Notes are guaranteed on a senior subordinated unsecured basis
by TD Group and TransDigm Inc.'s domestic restricted subsidiaries. The TransDigm
UK Notes are guaranteed on a senior subordinated basis by TransDigm Inc., TD
Group and TransDigm Inc.'s domestic restricted subsidiaries. The guarantees of
the Notes are subordinated to all of the guarantors' existing and future senior
debt, rank equally with all of their existing and future senior subordinated
debt and rank senior to all of their future debt that is expressly subordinated
to the guarantees of the Notes. The Notes are structurally subordinated to all
of the liabilities of TD Group's non-guarantor subsidiaries. The Notes contain
many of the restrictive covenants included in the Credit Agreement. TransDigm is
in compliance with all of the covenants contained in the Notes.
On January 30, 2019, the Company entered into a purchase agreement in connection
with a private offering of $3.8 billion aggregate principal amount in 6.25%
senior secured notes due 2026. In addition, on February 1, 2019, the Company
entered into a purchase agreement in connection with a private offering of $200
million aggregate principal amount of 6.25% senior secured notes due 2026. All
$4.0 billion aggregate principal amount of the secured notes will constitute a
single class and was issued under a single indenture (herein the "2026 Secured
Notes"). The notes in the first secured notes offering were issued at a price of
100% of their principal amount and the notes in the second secured notes
offering were issued at a price of 101% of their principal amount. The Notes are
guaranteed, with certain exceptions, by TransDigm Group, TransDigm UK and all of
TransDigm Inc.'s existing U.S. subsidiaries on a senior secured basis. The 2026
Secured Notes offerings closed on February 13, 2019 and mature on March 15,
2026.
On February 13, 2019, the Company announced a cash tender offer for any and all
of its outstanding 2020 Notes. On March 15, 2019, the Company redeemed the
principal amount of $550 million in 2020 Notes, plus accrued and unpaid interest
of approximately $12.6 million. The Company recorded refinancing costs of $1.7
million during the thirteen and thirty-nine week periods ended March 28, 2020
representing unamortized debt issuance costs expensed in conjunction with the
redemption of the 2020 Notes.
On March 14, 2019, in connection with the closing of the acquisition of
Esterline, the Company announced a cash tender offer for any and all of its
outstanding 2023 Notes. On April 15, 2019, the Company redeemed the principal
amount of approximately $373.8 million (€330.0 million as the 2023 Notes were
denominated in Euros), plus accrued interest of approximately $6.8 million,
early redemption premium of $6.8 million and fees of approximately $0.2 million.
On November 13, 2019, the Company issued $2,650 million in aggregate principal
amount of 5.50% Senior Subordinated Notes due 2027 (herein the "5.50% 2027
Notes") at an issue price of 100% of the principal amount thereof in a private
offering. The 2027 Notes were issued pursuant to an indenture, dated as of
November 13, 2019, among TransDigm, as issuer, TD Group, TD UK and the other
subsidiaries of TransDigm named therein, as guarantors.

                                       49

--------------------------------------------------------------------------------

Table of Contents



On November 26, 2019, the Company used a portion of the net proceeds from the
offering of the 5.50% 2027 Notes to redeem all of its outstanding 6.00% 2022
Notes. The Company redeemed the principal amount of $1,150 million, plus accrued
interest of approximately $25.5 million and early redemption premium of $17.3
million.
In April 2020, the Company executed two notes offerings for general Corporate
purposes, including increasing its liquidity as a result of the COVID-19
pandemic. On April 8, 2020, the Company entered into a purchase agreement in
connection with a private offering of $1,100 million in aggregate principal
amount of 8.00% Senior Secured Notes due 2025 at an issue price of 100% of the
principal amount. On April 17, 2020, the Company entered into a purchase
agreement in connection with a private offering of $400 million in aggregate
principal amount of 6.25% Senior Secured Notes due 2026 at an issue price of
101% of the principal amount. Refer to Note 9, "Debt," to the condensed
consolidated financial statements for further information.
Certain Restrictive Covenants in Our Debt Documents
The Credit Agreement and the Indentures governing the Notes contain restrictive
covenants that, among other things, limit the incurrence of additional
indebtedness, the payment of special dividends, transactions with affiliates,
asset sales, acquisitions, mergers and consolidations, liens and encumbrances,
and prepayments of certain other indebtedness.
The restrictive covenants included in the Credit Agreement are subject to
amendments executed periodically. The most recent amendment that impacted the
restrictive covenants contained in the Credit Agreement is Amendment No. 7. The
restrictive covenants are described above in the Recent Amendments to the Credit
Agreement section.
Under the terms of the Credit Agreement, TransDigm is entitled, on one or more
occasions, to request additional term loans or additional revolving commitments
to the extent that the existing or new lenders agree to provide such incremental
term loans or additional revolving commitments provided that, among other
conditions, our consolidated net leverage ratio would be no greater than 7.25 to
1.00 and the consolidated secured net debt ratio would be no greater than 5.00
to 1.00, in each case, after giving effect to such incremental term loans or
additional revolving commitments.
If any such default occurs, the lenders under the Credit Agreement and the
holders of the Notes may elect to declare all outstanding borrowings, together
with accrued interest and other amounts payable thereunder, to be immediately
due and payable. The lenders under the Credit Agreement also have the right in
these circumstances to terminate any commitments they have to provide further
borrowings. In addition, following an event of default under the Credit
Agreement, the lenders thereunder will have the right to proceed against the
collateral granted to them to secure the debt, which includes our available
cash, and they will also have the right to prevent us from making debt service
payments on the Notes.
As of March 28, 2020, the Company was in compliance with all of its debt
covenants.
Trade Receivables Securitization
During fiscal 2014, the Company established a trade receivable securitization
facility (the "Securitization Facility"). The Securitization Facility
effectively increases the Company's borrowing capacity depending on the amount
of the domestic operations' trade accounts receivable. The Securitization
Facility includes the right for the Company to exercise annual one year
extensions as long as there have been no termination events as defined by the
agreement. The Company uses the proceeds from the Securitization Facility as an
alternative to other forms of debt, effectively reducing borrowing costs.
On July 30, 2019, the Company amended the Securitization Facility to extend the
maturity date to July 28, 2020. As of March 28, 2020, the Company has borrowed
$350 million under the Securitization Facility, which bears interest at a rate
of 0.9% plus LIBOR. At March 28, 2020, the applicable interest rate was 2.5%.
The Securitization Facility is collateralized by substantially all of the
Company's domestic operations' trade accounts receivable.
Stock Repurchase Program
On November 8, 2017, our Board of Directors, authorized a stock repurchase
program permitting repurchases of our outstanding shares not to exceed $650
million in the aggregate, subject to any restrictions specified in the Credit
Agreement and/or Indentures governing the existing Notes.
During March 2020, the Company repurchased 36,900 shares of its common stock at
a gross cost of $18.9 million at the weighted average cost of $512.67 under the
$650 million stock repurchase program. As of March 28, 2020, the remaining
amount of repurchases allowable under the $650 million program was $631.1
million subject to any restrictions specified in the Credit Agreement and/or
Indentures governing the existing Notes.
Off-Balance Sheet Arrangements
The Company utilizes letters of credit to back certain payment and performance
obligations. Letters of credit are subject to limits based on amounts
outstanding under the Company's revolving credit facility. As of March 28, 2020,
the Company had $41.7 million in letters of credit outstanding.

                                       50

--------------------------------------------------------------------------------

Table of Contents



Non-GAAP Financial Measures
We present below certain financial information based on our EBITDA and EBITDA As
Defined. References to "EBITDA" mean earnings before interest, taxes,
depreciation and amortization, and references to "EBITDA As Defined" mean EBITDA
plus, as applicable for each relevant period, certain adjustments as set forth
in the reconciliations of net income to EBITDA and EBITDA As Defined and the
reconciliations of net cash provided by operating activities to EBITDA and
EBITDA As Defined presented below.
Neither EBITDA nor EBITDA As Defined is a measurement of financial performance
under accounting principles generally accepted in the United States of America
("US GAAP"). We present EBITDA and EBITDA As Defined because we believe they are
useful indicators for evaluating operating performance and liquidity.
Our management believes that EBITDA and EBITDA As Defined are useful as
indicators of liquidity because securities analysts, investors, rating agencies
and others use EBITDA to evaluate a company's ability to incur and service debt.
In addition, EBITDA As Defined is useful to investors because the revolving
credit facility under our senior secured credit facility requires compliance
under certain circumstances, on a pro forma basis, with a financial covenant
that measures the ratio of the amount of our secured indebtedness to the amount
of our Consolidated EBITDA defined in the same manner as we define EBITDA As
Defined herein.
In addition to the above, our management uses EBITDA As Defined to review and
assess the performance of the management team in connection with employee
incentive programs and to prepare its annual budget and financial projections.
Moreover, our management uses EBITDA As Defined to evaluate acquisitions.
Although we use EBITDA and EBITDA As Defined as measures to assess the
performance of our business and for the other purposes set forth above, the use
of these non-GAAP financial measures as analytical tools has limitations, and
you should not consider any of them in isolation, or as a substitute for
analysis of our results of operations as reported in accordance with US GAAP.
Some of these limitations are:
•     neither EBITDA nor EBITDA As Defined reflects the significant interest

expense, or the cash requirements, necessary to service interest payments

on our indebtedness;

• although depreciation and amortization are non-cash charges, the assets


      being depreciated and amortized will often have to be replaced in the
      future, and neither EBITDA nor EBITDA As Defined reflects any cash
      requirements for such replacements;

• the omission of the substantial amortization expense associated with our

intangible assets further limits the usefulness of EBITDA and EBITDA As

Defined;

• neither EBITDA nor EBITDA As Defined includes the payment of taxes, which

is a necessary element of our operations; and

• EBITDA As Defined excludes the cash expense we have incurred to integrate


      acquired businesses into our operations, which is a necessary element of
      certain of our acquisitions.


Because of these limitations, EBITDA and EBITDA As Defined should not be
considered as measures of discretionary cash available to us to invest in the
growth of our business. Management compensates for these limitations by not
viewing EBITDA or EBITDA As Defined in isolation and specifically by using other
US GAAP measures, such as net income, net sales and operating profit, to measure
our operating performance. Neither EBITDA nor EBITDA As Defined is a measurement
of financial performance under US GAAP, and neither should be considered as an
alternative to net income or cash flow from operations determined in accordance
with US GAAP. Our calculation of EBITDA and EBITDA As Defined may not be
comparable to the calculation of similarly titled measures reported by other
companies.

                                       51

--------------------------------------------------------------------------------

Table of Contents

The following table sets forth a reconciliation of net income to EBITDA and EBITDA As Defined (in millions):


                                             Thirteen Week Periods Ended               Twenty-Six Week Periods Ended
                                        March 28, 2020         March 30, 2019       March 28, 2020       March 30, 2019
Income from continuing operations      $         323         $            200     $            556     $            396

Adjustments:


Depreciation and amortization expense             72                       39                  141                   74
Interest expense, net                            252                      202                  501                  374
Income tax provision                              14                       63                   73                  117
EBITDA                                           661                      504                1,271                  961
Adjustments:
Inventory acquisition accounting
adjustments (1)                                    -                       16                    -                   20
Acquisition integration costs (2)                  9                        5                   15                    7
Acquisition transaction-related
expenses (3)                                       -                       17                    1                   22
Non-cash stock compensation expense
(4)                                               11                       21                   37                   38
Refinancing costs (5)                              3                        3                   26                    3
Other, net (6)                                    (9 )                      -                    6                    2
EBITDA As Defined                      $         675         $            566     $          1,356     $          1,053


(1) Represents accounting adjustments to inventory associated with acquisitions

of businesses and product lines that were charged to cost of sales when the

inventory was sold.

(2) Represents costs incurred to integrate acquired businesses and product


      lines into TD Group's operations, facility relocation costs and other
      acquisition-related costs.

(3) Represents transaction-related costs comprising deal fees, legal, financial

and tax due diligence expenses, and valuation costs that are required to be

expensed as incurred.

(4) Represents the compensation expense recognized by TD Group under our stock

incentive plans.

(5) Represents costs expensed related to debt financing activities, including

new issuances, extinguishments, refinancings and amendments to existing

agreements.

(6) Primarily represents foreign currency transaction gain or loss, payroll

withholding taxes related to dividend equivalent payments and stock option


      exercises, non-service related pension costs, deferred compensation, and
      gain or loss on sale of fixed assets.



                                       52

--------------------------------------------------------------------------------

Table of Contents

The following table sets forth a reconciliation of net cash provided by operating activities to EBITDA and EBITDA As Defined (in millions):


                                                            Twenty-Six Week 

Periods Ended


                                                          March 28, 2020      March 30, 2019
Net cash provided by operating activities                $         594       $          453
Adjustments:
Changes in assets and liabilities, net of effects from
acquisitions of businesses                                         173                   64
Interest expense, net (1)                                          485                  361
Income tax provision - current                                      82                  124
Non-cash stock compensation expense (2)                            (37 )                (38 )
Refinancing costs (3)                                              (26 )                 (3 )
EBITDA                                                           1,271                  961
Adjustments:
Inventory acquisition accounting adjustments (4)                     -                   20
Acquisition integration costs (5)                                   15                    7
Acquisition transaction-related expenses (6)                         1                   22
Non-cash stock compensation expense (2)                             37                   38
Refinancing costs (3)                                               26                    3
Other, net (7)                                                       6                    2
EBITDA As Defined                                        $       1,356       $        1,053

(1) Represents interest expense excluding the amortization of debt issuance

costs and premium and discount on debt.

(2) Represents the compensation expense recognized by TD Group under our stock

incentive plans.

(3) Represents costs expensed related to debt financing activities, including

new issuances, extinguishments, refinancings and amendments to existing

agreements.

(4) Represents accounting adjustments to inventory associated with acquisitions

of businesses and product lines that were charged to cost of sales when the

inventory was sold.

(5) Represents costs incurred to integrate acquired businesses and product


      lines into TD Group's operations, facility relocation costs and other
      acquisition-related costs.

(6) Represents transaction-related costs comprising deal fees; legal, financial

and tax due diligence expenses, and valuation costs that are required to be

expensed as incurred.

(7) Primarily represents foreign currency transaction gain or loss, payroll

withholding taxes related to dividend equivalent payments and stock option


      exercises, non-service related pension costs, deferred compensation, and
      gain or loss on sale of fixed assets.








                                       53

--------------------------------------------------------------------------------

Table of Contents

© Edgar Online, source Glimpses